Black Friday Sale! Save huge on InvestingProGet up to 60% off

Midday movers: Meta Platforms, Lilly rise; Arm, Moderna fall

Published 08/01/2024, 08:06 PM
Updated 08/01/2024, 11:50 PM
© Reuters
LLY
-
BIIB
-
COP
-
LH
-
WDC
-
SAVEQ
-
META
-
RACE
-
CVNA
-
MRNA
-
(Updated - August 1, 2024 11:44 AM EDT)

Investing.com -- U.S. stock futures declined Thursday after a measure of U.S. manufacturing activity dropped to an eight month low.

Here are some of the biggest U.S. stock movers today:

  • Meta Platforms (NASDAQ:META) stock fell 6.3% after the Facebook-parent reported stronger-than-expected second-quarter earnings and also presented a robust outlook.

  • Arm Holdings (ARM) stock fell 15% after the chip designer offered up a conservative revenue forecast, sparking worries that returns from a spending frenzy on AI computing would be relatively slow to materialize.

  • Moderna (NASDAQ:MRNA) (MRNA) stock slumped 18% after the drugmaker cut its full-year revenue guidance, citing low EU sales and a competitive vaccine environment in the U.S..

  • ConocoPhillips (NYSE:COP) stock fell 2% despite the oil and gas producer posting a second-quarter profit that beat estimates, benefiting from higher output and oil prices.

  • Ferrari (NYSE:RACE) stock rose 2% after the Italian luxury car manufacturer raised its forecasts for its full-year revenues core earnings, after it beat estimates in the second quarter.

  • Labcorp (LH) stock rose 6% after the lab operator beat expectations for second-quarter profit and revenue on strong demand for its diagnostic tests, and raised its sales growth forecast for the year.

  • Spirit Airlines (NYSE:SAVE) (SAVE) stock fell 7% after the carrier forecast its current-quarter revenue below estimates, as excess capacity and intense competition on its routes hamper its pricing power.

  • Biogen (NASDAQ:BIIB) stock fell 1.7% despite the drugmaker lifting its full-year earnings forecast, as the launch of new treatments and its cost-cutting program are expected to make up for falling sales of its older multiple sclerosis medicines.

  • Mobileye Global (NASDAQ:MBLY) (MBLY) stock fell 19% after the automotive tech company cut its annual revenue and profit forecasts, blaming volatile demand for its driver-assistance chips in China.

  • Eli Lilly (NYSE:LLY) rose 3% after its drug Zepbound demonstrated significant long-term health benefits for patients with obesity-related heart failure.

  • Carvana (CVNA) rose 9% after reporting strong revenue and operating profit in the second quarter. Analysts raised their price target on the stock today.

  • Western Digital (NASDAQ:WDC) fell 11% despite beating estimates for second quarter EPS, as guidance trailed consensus estimates. Its poor performance triggered analysts to downgrade the stock.


Additional reporting by Louis Juricic

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.